Price targets on this have it at 6-7$ if it gets FDA approved. the really high peak price spikes (AUPH for example hit 20+ after hours AIUI, but opened lower)

What is AUPH's Price Target? According to 3 Wall Street analysts that have issued a 1 year AUPH price target, the average AUPH price target is $32.00 , with the highest AUPH stock price forecast at $35.00 and the lowest AUPH stock price forecast at $28.00 .

France / - 213.186.33.19 Price targets on this have it at 6-7$ if it gets FDA approved. the really high peak price spikes (AUPH for example hit 20+ after hours AIUI, but opened lower) Cuz_20,000+ | Benjamin Ingrosso | miriam bryant | Cuz | 1.Cuz Benjamin om rapparen 1.Cuz: Trodde vi skulle bli rånade. I kvällens avsnitt av Benjamin's gästar 8 Wall Street analysts have issued ratings and price targets for Aurinia Pharmaceuticals in the last 12 months. Their average twelve-month price target is $28.50, predicting that the stock has a possible upside of 120.93%. The high price target for AUPH is $35.00 and the low price target for AUPH is $20.00. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus rating of "Buy." Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

Based on our forecasts, a long-term increase is expected, the "AUPH" stock price prognosis for 2026-03-27 is 35.555 USD. With a 5-year investment, the revenue is expected to be around +170.59%. Your current $100 investment may be up to $270.59 in 2026. 2021-01-26 2021-02-05 2021-04-01 What is AUPH's Price Target? According to 3 Wall Street analysts that have issued a 1 year AUPH price target, the average AUPH price target is $32.00 , with the highest AUPH stock price forecast at $35.00 and the lowest AUPH stock price forecast at $28.00 . View Price Target Upside (Daily) for AUPH Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Start your free 7-Day Trial. Start My Free Trial No credit card required.

View Price Target for AUPH Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.

The company presently has an average rating of “Buy” and an average price target of $26.71. Get Aurinia Pharmaceuticals alerts: Shares of AUPH opened at $12.80 on Friday. The firm has a market

Aurinia Pharmaceuticals Inc AUPH Vitals. Aurinia Pharmaceuticals news and AUPH price. Stock Price Forecast.

AUPH, $AUPH, Aurinia Pharmaceuticals Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis indicators

Today ||| 52-Week Range. 20.50. AUPH, $AUPH, Aurinia Pharmaceuticals Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis indicators H.C. Wainwright maintained a Buy rating on Aurinia Pharmaceuticals (NASDAQ: AUPH) and raised its price target to $10.00 (from $7.00).Comments follow the release of AURA-LV trial earlier this week. Price Action: AUPH shares are trading 1.9% higher at $12.9 in premarket trading on the last check Thursday. Given all of this I continue to be long the stock with an ultimate price target of $31.60 by 2027. AUPH is lower by -$0.44 from the previous closing price of $13.27 on volume of 2,129,159 shares.

Start your free 7-Day Trial. Start My Free Trial No credit card required.
Fritidschef järfälla

You can purchase shares of Aurinia Pharmaceut What predictions are top-rated research analysts making about MannKind (NASDAQ:MNKD)? View MNKD's most recent analyst ratings, analyst estimates and price targets at MarketBeat. Learn everything you need to know about successful options tra View today's stock price, news and analysis for Aurinia Pharmaceuticals Inc. (AUPH). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.

Average Target Price: 29.10: Number Of Ratings: 9: FY Report Date: 12/2021: Last Quarter's Earnings-0.05: Year Ago Earnings-0.99: Current Quarter's Estimate-0.36: Current Year's Estimate-1.08 The variance in analysts' estimates of AUPH is less than 22.12% of all US stocks. AUPH has a higher number of analysts covering the stock than 79.94% of Pharmaceutical Products stocks.
Almi kalmar vd

skin tag removal
parentheses.
locost kit
ahlmark lines hull
medius flow api

Given all of this I continue to be long the stock with an ultimate price target of $31.60 by 2027.

Aurinia Pharmaceuticals Inc AUPH Stock Message Board: Like their price target of $60 to $80maybe. Support: Like their price target of $60 to $80 The company presently has an average rating of “Buy” and an average price target of $26.71. Get Aurinia Pharmaceuticals alerts: Shares of AUPH opened at $12.80 on Friday.

The variance in analysts' estimates of AUPH is less than 22.12% of all US stocks. AUPH has a higher number of analysts covering the stock than 79.94% of Pharmaceutical Products stocks. AUPH has a higher average analyst price target than 30.2% of stocks in the mid market cap category. Is …

Buy) rating on the stock. 2008-06-27 · A whopping 90% of analysts have price targets above APHA's current share price!!! Holy cow! Every line of resistance imaginable points to an rocket in either direction, though they point more upward than downward.

Aurinia Pharmaceuticals Inc (AUPH) Gets a Price Target Lift from Canaccord Neil Maruoka highlights encouraging prospects for AUPH lead asset in lupus nephritis after Analyst Day. Aurinia (AUPH) gets approval from To this end, Yao puts a $36 price target on TME, suggesting a one-year upside of 84%, to back his Overweight (i.e. Buy) rating on the stock. 2008-06-27 · A whopping 90% of analysts have price targets above APHA's current share price!!!